Despite the headlines, Digital Health deals are getting done.

Obsidian Therapeutics , a startup founded nine years ago and headquartered in Cambridge, MA, is pioneering a tumor-infiltrating lymphocyte cell therapy program to treat melanoma and non-small cell lung cancer. Recently, the company secured a Series C funding round totaling $160.5 million, with Wellington Management leading the investment. Other participants in this round include Foresite Capital, Janus Henderson Investors, Novo Holdings A/S, Paradigm BioCapital, and RTW Investments.

Alterome Therapeutics, Inc , a San Diego-based startup founded three years ago, focuses on developing small molecule targeted therapies for cancer treatment. Recently, the company secured a $132 million Series B funding round led by Goldman Sachs. Other investors participating in this round include Canaan Partners, Invus, Driehaus Capital Management, Digitalis Ventures, and Blue Owl Capital, along with existing investors such as Orbimed, Nextech Invest, Vida Ventures, Boxer Capital, and Colt Ventures.

Varda Space Industries , a startup established four years ago in El Segundo, CA, focuses on manufacturing pharmaceutical products in space. Their goal is to leverage the distinct conditions of microgravity to create drugs that are impossible to produce on Earth. Recently, the company secured a $90 million Series B funding round led by Caffeinated Capital. Lux Capital, General Catalyst, Founders Fund, and Khosla Ventures also contributed to the investment. With this latest funding, Varda has raised $145 million.

binx health , a Boston-based company established 19 years ago, specializes in providing diagnostic tests for at-home and on-site use, with a primary focus on sexually transmitted infections. Recently, the company secured a $65 million Series F funding round, with Hildred Capital leading the investment and EQT Life Sciences also participating. This latest round brings the company's total raised funds to $250 million.

Biolinq , a San Diego-based company established 12 years ago, specializes in creating wearable biosensor patches to monitor blood glucose levels for individuals managing diabetes. The company, led by Alpha Wave Ventures, secured $58 million in funding. Other notable contributors to this funding round include Niterra, Pegasus Tech Ventures, as well as previous investors such as RiverVest Venture Partners, AXA IM Alts, Global Health Investment Corporation, Aphelion Capital, Senvest Management, Features Capital, and Taisho Pharmaceutical.

Selux Diagnostics, Inc , established a decade ago and headquartered in Charlestown, Massachusetts, specializes in creating advanced diagnostic tests for infectious diseases, particularly those caused by superbugs. Recently, the company secured a $48 million funding round, with RA Capital Management taking the lead. Northpond Ventures, Sands Capital, and Schooner Capital also invested.

ViaLase, Inc , a startup established five years ago and located in Aliso Viejo, California, is developing a novel laser treatment tailored for patients with glaucoma. Their goal is to offer a less invasive alternative to traditional surgeries. Recently, the company secured a $40 million funding round, with a new investor leading the investment, whose name remains undisclosed. Previous backers, including Venture Investors Health Fund, Arboretum Ventures, and Falcon Vision participated in this funding round.

EarliTec Diagnostics, Inc. , a startup founded five years ago and located in Decatur, Georgia, is dedicated to creating hardware and software solutions to identify and treat children with autism. The company recently closed a $21.5 million Series B funding round, with Nexus NeuroTech Ventures and Venture Investors Health Fund serving as co-leads in the investment.

Praia Health , a Chicago startup, has developed a platform enabling health systems to incorporate various consumer digital health services and applications seamlessly. Recently, the company secured a $20 million Series A funding round spearheaded by Frist Cressey Ventures. Other notable investors in this round include Epsilon Health Investors, Providence Ventures, and SignalFire.

Manifold, a startup founded eight years ago and headquartered in Newton, MA, offers an AI-powered platform tailored for clinical research. This platform aids researchers in streamlining study and data management processes while facilitating collaboration across institutions. Recently, the company secured a $15 million Series A funding round, with TQ Ventures leading the investment. Additional participants in this round include Calibrate Ventures, SK Ventures, and previous investor TTCER Partners.

Nucleai, a Tel Aviv-based startup founded six years ago, utilizes artificial intelligence to analyze pathology images for medical research and clinical diagnosis. Recently, the company secured a $14 million funding round, with M Ventures taking the lead, alongside investments from Section 32, Sanofi Ventures, Debiopharm, Fosun RZ Capital, Vertex Ventures Israel, and Grove Ventures.

Leash Biosciences, a startup based in Salt Lake City founded three years ago, specializes in utilizing AI and machine learning to forecast potential small-molecule drug candidates for various proteins. Recently, the company secured a $9.3 million seed funding round spearheaded by Springtide Ventures. Other notable contributors to the round include MetaPlanet, Top Harvest Capital, Mitsui Global Investment, and MFV Partners.

Scriptology , a startup headquartered in Atlanta, aims to tackle the costly problem of patients not adhering to medication regimens by providing personalized support and integrating with healthcare providers' teams. Recently, the company secured a $4 million seed round, with Redesign Health taking the lead in the transaction.

Funds

Autism Impact Fund, a venture capital firm established three years ago, invests in technology to detect and support patients with autism and other comorbidities. The firm recently closed its first fund, raising $60 million. Uber CEO Dara Khosrowshahi is among its limited partners (LPs).